Tyler Saint-Denis is a technology specialist whose practice focuses on the preparation and prosecution of domestic and foreign patent applications for university and emerging-technology clients. Dr. Saint-Denis works with clients in the pharmaceutical and chemical sectors; his practice covers biologically active small molecules, pharmaceutical candidates, nanomaterials, and stimuli-responsive materials for energy applications.

Prior to joining WilmerHale in 2026, he was a postdoctoral researcher at the University of California, Berkeley, where he developed synthetic methods involving single-atom transfer. Dr. Saint-Denis received his PhD from The Scripps Research Institute where he designed catalytic carbon-hydrogen bond activation reactions and interrogated their mechanisms. Prior to this, Dr. Saint-Denis received his BA in Chemistry from Columbia University.